Carlsbad, CA · Founded 2023 · Privately Held (backing)
Developer of lymph biomarkers designed for cancer diagnostics. ROSE Diagnostics is based in Carlsbad, CA and was founded in 2023. It has raised $3.4 million across 2 recorded rounds; the latest was a $2.3 million seed round in May 2025.
Last price · $/share
—
Implied valuation
—
Total raised
$3.4M
Last round
Seed Round
May 2025
Investors — not yet on record
No investors in ROSE Diagnostics are on record yet. Backers surface from round announcements, filings, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of ROSE Diagnostics with a free Private Market View account
·Watch ROSE Diagnostics: the Monday email on marks, rounds and moves
